Cva Family Office, LLC Adaptive Biotechnologies Corp Transaction History

Cva Family Office, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 11, 2022	BUY	$6.4 - $14.73 $1,760 - $4,050	275 Added 183.33%	425 $3,000
Q1 2022 Apr 22, 2022	SELL	$10.12 - $28.9 $404 - $1,156	-40 Reduced 21.05%	150 $2,000
Q4 2021 Jan 25, 2022	BUY	$25.17 - $36.85 $4,782 - $7,001	190 New	190 $5,000
Q3 2021 Oct 12, 2021	SELL	$30.02 - $39.87 $1,200 - $1,594	-40 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$32.22 - $44.59 $1,288 - $1,783	40 New	40 $2,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Cva Family Office, LLC with notifications on news.